Reasons to believe
Office of Inspector General (OIG) and Pharmaceutical Research and Manufacturers of America (PhRMA) compliant for ease of medical, legal, and regulatory review.
Patient education focus and absence of honoraria mean Sunshine Act reporting is unnecessary.
Creates enduring patient education materials for the clinician and care team to share to help improve outcomes (eg, adherence).